Exposure to GLP-1 receptor agonists may exacerbate oncogenic risk pathways
As AI tools continue to evolve, their role in bsAb discovery is expected to expand, and the new tools are expected to provide innovative solutions to longstanding challenges in biopharmaceutical research, ultimately improving the efficiency and success rate of antibody-based therapeutic development
Antisense oligonucleotides and gene-silencing approaches that directly target HTT expression are under investigation, yet have shown mixed results in clinical trials, with concerns about efficacy, safety, and delivery
Side effects and bad reactions are bound to happen when people take weight-loss medication on their own, and doing so only further stigmatizes these drugs for those that need them, Osborn says
1 Mounjaro isnt licensed specifically for kidney protection, so speak to your nephrologist about the potential benefits in your specific situation
Longhurst, H